Form 4: Agenus Director Timothy Wright Increases Stake Through Deferred Stock Units

Agenus Inc. Director Timothy Wright acquired 2,707.834 Deferred Stock Units valued at $3.462 each, increasing his total beneficial ownership to 20,167.502 units.

Summary

• Timothy Wright, a Director of Agenus Inc., acquired 2,707.834 Deferred Stock Units (DSUs).
• The acquisition occurred on July 1, 2025.
• Each DSU was valued at $3.462, based on the average closing price of Agenus common stock for the calendar quarter immediately preceding the acquisition date.
• DSUs convert to common stock on a 1-for-1 basis.
• These units were acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan.
• Following this transaction, Timothy Wright beneficially owns a total of 20,167.502 Deferred Stock Units.
• DSUs are typically distributed as common stock once the director ceases to serve.

Sentiment

Score: 6

Explanation: The filing indicates a routine acquisition of deferred stock units by a director as part of a compensation plan, which is a neutral event. However, the increase in beneficial ownership by a director can be viewed as a slight positive, indicating continued alignment of interests.

Positives

• Director Timothy Wright increased his beneficial ownership in Agenus Inc. by acquiring additional Deferred Stock Units, signaling continued confidence in the company.
• The acquisition of DSUs under a deferred compensation plan aligns the director's long-term interests with those of shareholders.

Negatives

• NA

Risks

• NA

Future Outlook

Deferred Stock Units are expected to convert to shares of Common Stock on a 1 for 1 basis and are typically distributed once the director ceases to serve as a director of the company.

Management Comments

• NA

Industry Context

This transaction represents a routine compensation event for a director, common in publicly traded companies across various sectors, including biotechnology. The use of Deferred Stock Units is a standard practice to align director incentives with long-term shareholder value.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• NA

Related Party Transactions

• Acquisition of Deferred Stock Units by Director Timothy Wright under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan.

Stakeholder Impact

• Shareholders: The increase in director ownership through deferred stock units aligns the director's long-term interests with those of shareholders, potentially fostering greater commitment to long-term value creation.

Next Steps

• Deferred Stock Units will be distributed as common stock once Timothy Wright ceases to serve as a director of Agenus Inc.

Key Dates

Keywords

Agenus Inc., AGEN, Form 4, Insider Transaction, Director Compensation, Deferred Stock Units, Equity Acquisition, Timothy Wright, Biotechnology, Pharmaceuticals